PHVS Pharvaris N.V.
Healthcare$29.88+0.67%ClosedMarket Cap: $1.95B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
7.04
P/S
0.00
EV/EBITDA
-8.37
DCF Value
$5.70
FCF Yield
-8.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-67.4%
ROA
-65.1%
ROIC
-72.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-45.0M | $-39.8M | $— | — |
| Q4 null | $0.00 | NaN% | $-47.6M | $-46.7M | $— | — |
| FY null | $0.00 | NaN% | $-169.8M | $-175.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-39.7M | $-37.1M | $— | — |
| Q2 null | $0.00 | NaN% | $-40.4M | $-45.5M | $— | — |
| Q1 null | $0.00 | NaN% | $42.2M | $-46.3M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-48.1M | $-37.1M | $— | — |
| FY null | $0.00 | NaN% | $-145.7M | $-134.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-37.9M | $-41.7M | $— | — |
| Q2 null | $0.00 | NaN% | $-34.4M | $-29.7M | $— | — |
| Q1 null | $0.00 | NaN% | $-28.3M | $-28.0M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-29.2M | $-35.2M | $-0.61 | — |